Spyre Therapeutics, Inc. — 3 Filings
41 3 filings on record
This page lists all 3 filings submitted to the SEC by Spyre Therapeutics, Inc. (SYRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Spyre Therapeutics, Inc. has filed 41 3 documents with the SEC since 2015. To view all SEC filings by Spyre Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | FORM 3 | 0001636282-24-000066 | Oct 1, 2024 | — |
| 3 | 3 | 0000950170-24-061074 | May 16, 2024 | May 14, 2024 |
| 3 | 3 | 0000950170-24-011360 | Feb 5, 2024 | Feb 1, 2024 |
| 3 | 3 | 0000950170-23-066141 | Nov 27, 2023 | Nov 22, 2023 |
| 3 | 3 | 0000950170-23-066136 | Nov 27, 2023 | Nov 22, 2023 |
| 3 | 3 | 0000950170-23-046385 | Sep 5, 2023 | Sep 1, 2023 |
| 3 | 3 | 0000950170-23-046380 | Sep 5, 2023 | Sep 1, 2023 |
| 3 | 3 | 0000950170-23-031185 | Jun 30, 2023 | Jun 22, 2023 |
| 3 | 3 | 0000950170-23-031168 | Jun 30, 2023 | Jun 22, 2023 |
| 3 | 3 | 0000950170-23-031167 | Jun 30, 2023 | Jun 22, 2023 |
| 3 | FORM 3 SUBMISSION | 0001209191-23-005349 | Jan 27, 2023 | Nov 14, 2022 |
| 3 | FORM 3 SUBMISSION | 0001209191-22-059261 | Dec 1, 2022 | Nov 29, 2022 |
| 3 | FORM 3 SUBMISSION | 0001209191-22-047655 | Aug 25, 2022 | Aug 23, 2022 |
| 3 | FORM 3 SUBMISSION | 0001209191-21-064769 | Nov 16, 2021 | Nov 12, 2021 |
| 3 | FORM 3 SUBMISSION | 0001209191-21-046006 | Jul 8, 2021 | Jul 6, 2021 |
| 3 | FORM 3 SUBMISSION | 0001209191-21-042376 | Jun 22, 2021 | Jun 18, 2021 |
| 3 | PRIMARY DOCUMENT | 0001638599-21-000271 | Feb 25, 2021 | Feb 23, 2021 |
| 3 | PRIMARY DOCUMENT | 0001638599-21-000270 | Feb 25, 2021 | Feb 23, 2021 |
| 3 | FORM 3 SUBMISSION | 0001209191-21-008623 | Feb 8, 2021 | Feb 2, 2021 |
| 3 | FORM 3 SUBMISSION | 0001209191-20-064060 | Dec 17, 2020 | Dec 15, 2020 |
| 3 | FORM 3 | 0001567619-19-020398 | Nov 4, 2019 | Nov 1, 2019 |
| 3 | FORM 3 | 0001567619-19-019921 | Oct 23, 2019 | Oct 21, 2019 |
| 3 | FORM 3 | 0001567619-19-006484 | Mar 8, 2019 | Mar 6, 2019 |
| 3 | FORM 3 | 0001140361-18-032715 | Jul 17, 2018 | Jul 13, 2018 |
| 3 | FORM 3 | 0001140361-18-014888 | Mar 26, 2018 | Mar 22, 2018 |
| 3 | FORM 3 | 0001140361-17-027543 | Jul 10, 2017 | — |
| 3 | FORM 3 | 0001140361-17-025046 | Jun 14, 2017 | May 22, 2017 |
| 3 | FORM 3 | 0001140361-17-007978 | Feb 16, 2017 | Feb 15, 2017 |
| 3 | FORM 3 | 0001140361-16-066303 | May 19, 2016 | May 17, 2016 |
| 3 | FORM 3 | 0001140361-16-061550 | Apr 19, 2016 | Apr 12, 2016 |
| 3 | FORM 3 | 0001140361-16-060475 | Apr 6, 2016 | — |
| 3 | FORM 3 | 0001140361-16-060474 | Apr 6, 2016 | — |
| 3 | FORM 3 | 0001140361-16-060473 | Apr 6, 2016 | — |
| 3 | FORM 3 | 0001140361-16-060472 | Apr 6, 2016 | — |
| 3 | FORM 3 | 0001140361-16-060471 | Apr 6, 2016 | — |
| 3 | FORM 3 | 0001140361-16-060470 | Apr 6, 2016 | — |
| 3 | FORM 3 | 0001140361-16-060468 | Apr 6, 2016 | — |
| 3 | FORM 3 | 0001140361-16-060467 | Apr 6, 2016 | — |
| 3 | FORM 3 | 0001140361-16-060466 | Apr 6, 2016 | — |
| 3 | FORM 3 | 0001140361-16-060465 | Apr 6, 2016 | — |
| 3 | FORM 3 | 0001140361-16-060462 | Apr 6, 2016 | — |